Answers are grounded in this paper and cite their sources.
Focusing on the disrupted skin barrier as a target for both prevention and treatment and incorporating a combined strategy that utilizes the aforementioned agents to tackle barrier dysfunction from different angles remains a promising area for clinical impact in dermatology.
No takes yet. Share an insight, caveat, or question.
Chandan et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: